Dr Reddy's Labs unveils cancer drug Lenalidomide in US Ruchika Sharma8 Sept 2022 2:47 PM ISTDr. Reddy's Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg,...
Cipla Cancer drug Lenalidomide bags USFDA okay Ruchika Sharma7 Sept 2022 4:22 PM ISTMumbai: Drugmaker, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application (ANDA) for...
AstraZeneca new tablet formulation of Calquence gets USFDA okay Ruchika Sharma8 Aug 2022 12:30 PM IST"The tablet can be taken with gastric acid-reducing agents, including proton pump inhibitors (PPIs), antacids and H2-receptor antagonists (H2RAs),"...
Ibrutinib with Chemoimmunotherapy Improved Progression-Free Survival of Newly Diagnosed Mantle Cell Lymphoma Patients Dr. Kamal Kant Kohli10 Jun 2022 7:15 PM ISTCombination chemoimmunotherapy with the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib demonstrated improved progression-free survival over...
Phase 3 SHINE results show postive results for IMBRUVICA (ibrutinib) in Mantle Cell Lymphoma Ruchika Sharma5 Jun 2022 3:00 PM ISTMCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.
Gland Pharma launches cancer drug Bortezomib in US Ruchika Sharma5 May 2022 12:06 PM ISTHyderabad: Gland Pharma Limited, a generic injectable focused pharmaceutical company, through its partner has launched Bortezomib for Injection, 3.5 ...
Aurobindo Pharma arm bags USFDA nod for cancer drug Bortezomib Ruchika Sharma4 May 2022 11:00 AM ISTHyderabad: Drugmaker, Aurobindo Pharma Limited, has recently announced that its wholly owned subsidiary company, Eugia Pharma Specialties...
Zydus Lifesciences bags USFDA nod for Bortezomib for Injection to treat cancer Ruchika Sharma3 May 2022 3:26 PM ISTThe drug will be manufactured at Zydus Hospira.
FDA Approves First Cell-Based Gene Therapy for Relapsed or Refractory MCL Hina Zahid26 July 2020 2:15 PM ISTThe U.S. Food and Drug Administration approved Tecartus (brexucabtagene autoleucel) for treatment of adult patients diagnosed with mantle cell...
